BioSpace News Archive

ERYTECH to Participate in the Citi 16th Annual BioPharma Conference

MedAvail to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Ligand Pharmaceuticals Incorporated today announced that its partner Gloria Biosciences (GloriaBio) has received approval from China’s National Medical Products Administration (NMPA) for zimberelimab (GLS-010), an OmniAb-derived anti-PD-1 monoclonal antibody for the treatment of recurrent or refractory classical Hodgkin’s lymphoma (cHL).

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following virtual investor conferences

Opthea Limited, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, reported financial results for the year ended June 30, 2021 and provided an overview of recent progress and accomplishments.

Microalgae cultivation start-up Yemoja Ltd. is joining the MIGAL Galilee Research institute to spearhead an extensive, four-year research initiative to identify algae-sourced compounds with the potential to help manage inflammation and Inflammatory Bowel Disease.

UCB announced that the U.S. Food and Drug Administration has approved an expanded indication for BRIVIACT CV tablets, oral solution, and injection to treat partial-onset seizures in patients as young as one month of age.

Kinnov-Therapeutics today announced the completion of patient enrollment in its Phase 2 clinical trial (study COKTAIL) evaluating its lead drug candidate, KT-110, in its first program, alcohol use disorders.

Sonnet BioTherapeutics Holdings, Inc., announced today that it has selected a novel development candidate after completing comparative studies in a mouse melanoma model.

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Wells Fargo Virtual Healthcare Conference.